Lisa Jackson

16PUBLICATIONS

93CO-AUTHORS

Epidemiological modellingInnate immunityMedical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyAgricultural molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 08, 2026

Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021-23.

|Feb 25, 2026

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Noemia S Lima, Lauren McCormick, Samuel Li

|Nov 19, 2025

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.

David Fitz-Patrick, Donald S McVinnie, Lisa A Jackson

|Oct 10, 2025

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

David M Dobrzynski, Daniel S Graciaa, Tara M Babu

|Apr 29, 2025

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar, Kirsten E Lyke, Christine M Posavad

|Oct 16, 2024

Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration.

Tara M Babu, Lisa A Jackson, Hana M El Sahly

Pageof 3

Frequent Collaborators

John H Beigel

Nicole Doria-Rose

Evan J Anderson

Barney S Graham

Alicia T Widge

Christina A Rostad

Meagan E Deming

Robert L Atmar

Paul C Roberts

Sean C Murphy

Frequent Collaborators

John H Beigel

Nicole Doria-Rose

Evan J Anderson

Barney S Graham